First Trust Direct Indexing’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,895
Closed -$329K 666
2022
Q2
$329K Buy
2,895
+331
+13% +$38K 0.05% 446
2022
Q1
$332K Sell
2,564
-212
-8% -$30.6K 0.04% 471
2021
Q4
$501K Buy
2,776
+173
+7% +$30K 0.06% 354
2021
Q3
$386K Buy
2,603
+110
+4% +$16.9K 0.05% 407
2021
Q2
$378K Buy
2,493
+112
+5% +$15.6K 0.06% 401
2021
Q1
$309K Buy
2,381
+111
+5% +$14.2K 0.08% 303
2020
Q4
$272K Buy
+2,270
New +$223K 0.07% 306

Other funds holding OMCL

First Trust Direct Indexing's OMCL Position: Q3 2022 in Review

First Trust Direct Indexing sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 2,895 shares — an estimated $329K sold.

First Trust Direct Indexing first reported a position in OMCL in Q4 2020 and held it in 7 quarters. The position peaked at $501K in Q4 2021. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

  • First Trust Direct Indexing reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
  • First Trust Direct Indexing sold 2,895 Omnicell shares in Q3 2022, an estimated $329K.
  • First Trust Direct Indexing first reported a position in Omnicell in Q4 2020 and held it in 7 quarters.
  • First Trust Direct Indexing's Omnicell position peaked at $501K in Q4 2021.
  • 374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on First Trust Direct Indexing's 13F filing for Q3 2022, filed 27 Oct 2022.